Two genetically-related multidrug-resistant Mycobacterium tuberculosis strains induce divergent outcomes of infection in two human macrophage models
Tài liệu tham khảo
Alonso, 2010, Characterization of Mycobacterium tuberculosis Beijing isolates from the Mediterranean area, BMC Microbiol., 10, 151, 10.1186/1471-2180-10-151
Brites, 2011, Old and new selective pressures on Mycobacterium tuberculosis, Infect. Genet. Evol., 12, 678, 10.1016/j.meegid.2011.08.010
Caws, 2008, The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis, PLoS Pathog., 4, e1000034, 10.1371/journal.ppat.1000034
Chacón-Salinas, 2005, Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes, Clin. Exp. Immunol., 140, 443, 10.1111/j.1365-2249.2005.02797.x
Dao, 2008, Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production, PLoS Pathog., 4, e1000081, 10.1371/journal.ppat.1000081
Diaz-Silvestre, 2005, The 19-kDa antigen of Mycobacterium tuberculosis is a major adhesin that binds the mannose receptor of THP-1 monocytic cells and promotes phagocytosis of mycobacteria, Microb. Pathog., 39, 97, 10.1016/j.micpath.2005.06.002
Dormans, 2004, Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model, Clin. Exp. Immunol., 137, 460, 10.1111/j.1365-2249.2004.02551.x
Flynn, 2005, What’s good for the host is good for the bug, Trends Microbiol., 13, 98, 10.1016/j.tim.2005.01.005
Geffner, 2009, Patients with multidrug resistant tuberculosis display impaired Th1 response and enhanced regulatory T cells levels in response to M and Ra outbreak multidrug resistant Mycobacterium tuberculosis strains, Infect. Immun., 77, 5025, 10.1128/IAI.00224-09
Harris, 1985, Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines, J. Leukoc. Biol., 37, 407, 10.1002/jlb.37.4.407
Henao, 2007, Human splenic macrophages as a model for in vitro infection with Mycobacterium tuberculosis, Tuberculosis, 87, 509, 10.1016/j.tube.2007.07.002
Hoal-van Helden, 2001, Mycobacterial growth in human macrophages: variation according to donor, inoculum and bacterial strain, Cell Biol. Int., 25, 71, 10.1006/cbir.2000.0679
Homolka, 2010, Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival, PLoS Pathog., 6, e1000988, 10.1371/journal.ppat.1000988
Kamerbeek, 1997, Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J. Clin. Microbiol., 35, 907, 10.1128/JCM.35.4.907-914.1997
Kang, 2005, The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis, J. Exp. Med., 202, 987, 10.1084/jem.20051239
Krishnan, 2011, Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles, PLoS ONE, 6, e23870, 10.1371/journal.pone.0023870
Li, 2002, Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model, Infect. Immun., 70, 6489, 10.1128/IAI.70.11.6489-6493.2002
López, 2003, A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes, Clin. Exp. Immunol., 133, 30, 10.1046/j.1365-2249.2003.02171.x
Manca, 1999, Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates, J. Immunol., 162, 6740, 10.4049/jimmunol.162.11.6740
Manca, 2004, Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis, Infect. Immun., 72, 5511, 10.1128/IAI.72.9.5511-5514.2004
Marquina-Castillo, 2009, Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model, Immunology, 128, 123, 10.1111/j.1365-2567.2008.03004.x
Mathema, 2012, Epidemiologic consequences of microvariation in Mycobacterium tuberculosis, J. Infect. Dis., 205, 964, 10.1093/infdis/jir876
Nau, 2002, Human macrophage activation programs induced by bacterial pathogens, Proc. Natl. Acad. Sci. USA, 99, 1503, 10.1073/pnas.022649799
Palmero, 2003, Multidrug-resistant tuberculosis in HIV-negative patients, Buenos Aires, Argentina, Emerg. Infect. Dis., 9, 965, 10.3201/eid0908.020474
Paolo, 2004, Tuberculosis in New York city: recent lessons and a look ahead, Lancet Infect. Dis., 4, 287, 10.1016/S1473-3099(04)01004-7
Parwati, 2010, Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains, Lancet Infect. Dis., 10, 103, 10.1016/S1473-3099(09)70330-5
Portevin, 2011, Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages, PLoS Pathog., 7, e1001307, 10.1371/journal.ppat.1001307
Rajaram, 2010, Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses, J. Immunol., 185, 929, 10.4049/jimmunol.1000866
Reed, 2004, A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response, Nature, 431, 84, 10.1038/nature02837
Ritacco, 1997, Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires, J. Infect. Dis., 176, 637, 10.1086/514084
Ritacco, 2012, Conspicuous multidrug-resistant Mycobacterium tuberculosis cluster strains do not trespass country borders in Latin America and Spain, Infect. Genet. Evol., 12, 711, 10.1016/j.meegid.2011.06.006
Ritacco, 2012, HIV infection and geographically bound transmission driving multidrug- and extensively drug-resistant tuberculosis in Argentina, Emerg. Infect. Dis., 18, 1802, 10.3201/eid1811.120126
Schäfer, 2009, Non-opsonic recognition of Mycobacterium tuberculosis by phagocytes, J. Innate Immun., 1, 231, 10.1159/000173703
Theus, 2004, Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates, Infect. Immun., 72, 1169, 10.1128/IAI.72.2.1169-1173.2004
Theus, 2005, Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics, J. Infect. Dis., 191, 453, 10.1086/425936
Theus, 2006, Differences in the growth of paired Ugandan isolates of Mycobacterium tuberculosis within human mononuclear phagocytes correlate with epidemiological evidence of strain virulence, Infect. Immun., 74, 6865, 10.1128/IAI.00561-06
Theus, 2007, Beijing family Mycobacterium tuberculosis strains differ in their intracellular growth in THP-1 macrophages, Int. J. Tuberc. Lung Dis., 11, 1087
Tsenova, 2005, Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli, J. Infect. Dis., 192, 98, 10.1086/430614
Valway, 1998, An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis, N. Engl. J. Med., 338, 633, 10.1056/NEJM199803053381001
van Embden, 1993, Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology, J. Clin. Microbiol., 31, 406, 10.1128/JCM.31.2.406-409.1993
Wang, 2010, Innate immune response to Mycobacterium tuberculosis Beijing and other genotypes, PLoS ONE, 5, e13594, 10.1371/journal.pone.0013594
Yokobori, 2012, Differential induction of macrophage cell death by antigens of a clustered and a non-clustered multidrug-resistant Mycobacterium tuberculosis strain from Haarlem family, FEMS Immunol. Med. Microbiol., 66, 363, 10.1111/j.1574-695X.2012.01024.x
Zhang, 1999, Enhanced Capacity of a Widespread Strain of Mycobacterium tuberculosis to Grow in Human Macrophages, J. Infect. Dis., 179, 1213, 10.1086/314738